Nicotinamide Riboside Dosage, half-life & reference guide

Also known as NR · Niagen · Nicotinamide riboside chloride · NR chloride · Tru Niagen

Reviewed Evidence: ModeratePublished by PepVault

A form of vitamin B3 that the body builds into NAD+, a molecule cells use for energy and repair. It reliably raises NAD+ in blood, about as well as NMN. The health effects have been underwhelming so far: no gain in insulin sensitivity in obese men, a better walking distance in leg-artery disease, and slightly worse symptoms than placebo in a year-long Parkinson trial. Mice in the NIA's testing program did not live longer on it.

Studied range
300–1000 mg
How often
Daily
Evidence
●●● Moderate
Route
Oral capsule

Studied in research — not a recommendation.

How it works.

A form of vitamin B3 that the body turns into NAD+, the molecule cells need for energy metabolism and for repair enzymes such as sirtuins and PARPs. NAD+ falls in some tissues with age, and the idea is that topping up the precursor restores it. NR reliably raises NAD+ in blood: by about half at 300 mg a day and more than double at 1,000 mg in an 8-week trial, about as much as NMN in a 2026 head-to-head. What that does for health is less clear: trials found no change in insulin sensitivity, mixed results for muscle, and in a large Parkinson trial, slightly worse symptoms than placebo.

Commonly reported: Nothing much felt.

Your report

Taken Nicotinamide Riboside? What did you notice?

One tap to start. About 30 seconds, no account.

A smiling woman with silver hair in a grey training top by a window, holding her phone

PepVault for iPhone

Track Nicotinamide Riboside in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Week by week.

What to expect in the first 8 weeks

Onset
Hours (blood NAD+ after a dose); 2 weeks to a steady higher level
Peak effect
2 weeks (blood NAD+)
Duration
Ongoing; trials ran 2–52 weeks
  1. Day 1–14RCT

    NAD+ in the blood climbs fast

    Blood NAD+ rises within hours of a dose and settles at a higher level within two weeks of daily use. That part is well measured; what the higher level does is the open question.

    The science

    Trammell 2016: single doses of 100, 300 and 1,000 mg raised the blood NAD+ metabolome dose-dependently, with NAAD the most sensitive marker. Conze 2019: 8 weeks in overweight adults, whole-blood NAD+ +22%, +51% and +142% at 100, 300 and 1,000 mg a day within 2 weeks, maintained to the end, with no flushing and adverse events like placebo.

    Sources
    • Trammell et al. (2016)
    • Conze et al. (2019)

    Updated Nov 2026

  2. Day 14–84RCT

    Metabolism mostly stays the same

    In obese men, three months at a high dose did not change insulin sensitivity, fat burning or body composition. Commonly reported: little to feel, beyond the routine of a daily capsule.

    The science

    Dollerup 2018: 40 sedentary men with BMI above 30, aged 40–70, 1,000 mg twice daily or placebo for 12 weeks; clamp-measured insulin sensitivity, glucose production and disposal, resting energy expenditure, lipolysis and body composition not improved; no serious adverse events. Martens 2018 (crossover, healthy middle-aged and older adults) found it well tolerated and flagged blood pressure and arterial stiffness for further study.

    Sources
    • Dollerup et al. (2018)
    • Martens et al. (2018)

    Updated Nov 2026

  3. Any dayRCT

    What NR is built on

    NR is one of the best-measured NAD+ precursors: it raises NAD+ in people reliably and looks safe. The benefits have not followed: no metabolic gain, no muscle gain in older adults, a setback in Parkinson disease, and no longer life in the NIA's mice.

    The science

    Prokopidis 2025 (meta-analysis, adults over 60): no support for NMN or NR preserving muscle mass or function; NR linked to longer walking distance in PAD but lower SPPB and slower chair stands in mild cognitive impairment. ITP: Harrison 2021, nicotinamide riboside did not increase lifespan in either sex. Conze 2019: a crystal form of NR chloride is GRAS for foods.

    Sources
    • Prokopidis et al. (2025)
    • Harrison et al. (2021)
    • Conze et al. (2019)

    Updated Nov 2026

  4. With NMN and NAD+RCT

    NR or NMN: about the same in the blood

    In the first head-to-head in people, NR and NMN raised blood NAD+ about equally over two weeks, while plain nicotinamide did not. Taking both adds a second route to the same molecule, not a different effect; the pair has not been studied together.

    The science

    Christen 2026 (Nat Metab): randomized, open-label, placebo-controlled, 65 healthy adults, 14 days; NR and NMN comparably increased circulating NAD+, nicotinamide did not; ex vivo, both were converted by gut microbes to nicotinic acid, a potent NAD+ booster, suggesting part of their effect runs through the gut.

    Sources
    • Christen et al. (Nature Metabolism) (2026)

    Updated Nov 2026

After week 8

  1. Day 84–365RCT

    Longer trials: one gain, one setback

    In people with narrowed leg arteries, six months of NR added walking distance against placebo. In a year-long trial in early Parkinson disease, it did not help, and symptom scores rose slightly more than on placebo.

    The science

    McDermott 2024 (NICE): 90 people with peripheral artery disease, 6 months; 6-minute walk +7.0 vs −10.6 m, difference +17.6 m (90% CI +1.8 to ∞); resveratrol added no benefit. Brakedal 2026 (NOPARK, JAMA; NCT03568968, Haukeland University Hospital): 410 randomized, 500 mg twice daily for 52 weeks; MDS-UPDRS +2.45 on NR vs −0.27 on placebo (difference 2.72, P = .02, favouring placebo); non-motor symptoms worse on NR (P = .009); serious adverse events 8.3% vs 14.1%.

    Sources
    • McDermott et al. (NICE) (2024)
    • Brakedal et al. (NOPARK) (2026)

    Updated Nov 2026

Day 1 is the day you start it.

Randomized placebo-controlled trials (small metabolic trials and a 410-person phase 3), a 2025 meta-analysis and the ITP mouse study. No trial measured lifespan.

Moderate evidence

A typical run.

Run notes

Cycle
Taken daily in the trials, from 2 weeks to 52 weeks; the rise in blood NAD+ held for as long as people kept taking it.Community practice — opinions vary. Not a clinical recommendation.
Timing
Once or twice a day; the 1,000 mg trials split it into 500 mg twice daily. No trial compared times of day.
Route
Oral capsule
Stacks
NMN, NAD+, Resveratrol

Track it in the app

Safety.

Common side effects

  • Usually none above placebo in the trials
  • No flushing at the studied doses

Interactions

No drug interactions are reported in the trials read. It is a form of vitamin B3, worth counting with other niacin or nicotinamide supplements. Discuss any prescription medications with your clinician.

Safety notes

A dietary supplement; one crystal form is generally recognized as safe for foods. In trials of up to 2,000 mg a day for 12 weeks, adverse events did not differ from placebo, blood safety tests stayed normal, LDL cholesterol did not rise and there was no flushing. In the 52-week NOPARK trial in early Parkinson disease, serious adverse events were fewer on NR than on placebo, but symptom scores worsened slightly more on NR. Discuss with your clinician, especially with Parkinson disease.

Questions people ask.

What is Nicotinamide Riboside?

A form of vitamin B3 that the body builds into NAD+, a molecule cells use for energy and repair. It reliably raises NAD+ in blood, about as well as NMN. The health effects have been underwhelming so far: no gain in insulin sensitivity in obese men, a better walking distance in leg-artery disease, and slightly worse symptoms than placebo in a year-long Parkinson trial. Mice in the NIA's testing program did not live longer on it.

How is Nicotinamide Riboside dosed in research?

The research range for Nicotinamide Riboside is 300–1000 mg, daily. Studied in research — not a recommendation.

How long does Nicotinamide Riboside last?

The half-life of Nicotinamide Riboside is not a single number: blood NAD+ rises within hours of a dose and stays higher with daily use (Trammell 2016; Conze 2019); NR itself is converted quickly.

What do people report on Nicotinamide Riboside?

Commonly reported on Nicotinamide Riboside: nothing much felt.

Is Nicotinamide Riboside safe?

The research basis for Nicotinamide Riboside is moderate: animal studies + some human data. Common side effects in the library: usually none above placebo in the trials and no flushing at the studied doses.

What does Nicotinamide Riboside stack with?

Common stacks for Nicotinamide Riboside: NMN, NAD+ and Resveratrol.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Daily

Half-life

Not a single number: blood NAD+ rises within hours of a dose and stays higher with daily use (Trammell 2016; Conze 2019); NR itself is converted quickly

Research basis

●●● Moderate

Animal studies + some human data

PepVault for iPhone

Track Nicotinamide Riboside in PepVault

Log each dose and keep your schedule and step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library